BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2170 related articles for article (PubMed ID: 10893575)

  • 1. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    Itano NB; Blute ML; Spotts B; Zincke H
    J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma.
    Schrodter S; Hakenberg OW; Manseck A; Leike S; Wirth MP
    J Urol; 2002 Apr; 167(4):1630-3. PubMed ID: 11912377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
    Canfield SE; Kamat AM; Sánchez-Ortiz RF; Detry M; Swanson DA; Wood CG
    J Urol; 2006 Mar; 175(3 Pt 1):864-9. PubMed ID: 16469567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma.
    Hafez KS; Novick AC; Campbell SC
    J Urol; 1997 Jun; 157(6):2067-70. PubMed ID: 9146581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of isolated renal fossa recurrence following radical nephrectomy.
    Master VA; Gottschalk AR; Kane C; Carroll PR
    J Urol; 2005 Aug; 174(2):473-7; discussion 477. PubMed ID: 16006867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate.
    Permpongkosol S; Bagga HS; Romero FR; Sroka M; Jarrett TW; Kavoussi LR
    J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival.
    Bruno JJ; Snyder ME; Motzer RJ; Russo P
    BJU Int; 2006 May; 97(5):933-8. PubMed ID: 16643473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single center preliminary experience with hand-assisted laparoscopic resection of isolated renal cell carcinoma fossa recurrences.
    Bandi G; Wen CC; Moon TD; Nakada SY
    Urology; 2008 Mar; 71(3):495-9; discussion 499-500. PubMed ID: 18342195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.
    Thompson RH; Boorjian SA; Lohse CM; Leibovich BC; Kwon ED; Cheville JC; Blute ML
    J Urol; 2008 Feb; 179(2):468-71; discussion 472-3. PubMed ID: 18076931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma.
    Levy DA; Slaton JW; Swanson DA; Dinney CP
    J Urol; 1998 Apr; 159(4):1163-7. PubMed ID: 9507823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
    Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
    J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
    Carini M; Minervini A; Lapini A; Masieri L; Serni S
    J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis.
    Patel A; Soonawalla P; Shepherd SF; Dearnaley DP; Kellett MJ; Woodhouse CR
    J Urol; 1996 Mar; 155(3):868-74. PubMed ID: 8583595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
    Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M
    J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 7-year oncological outcomes after laparoscopic and open partial nephrectomy.
    Lane BR; Gill IS
    J Urol; 2010 Feb; 183(2):473-9. PubMed ID: 20006866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 109.